Log in
Enquire now
Rodin Therapeutics

Rodin Therapeutics

Rodin Therapeutics was a biotechnology company that developed treatments for Alzheimer's disease. Founded in 2013, it was acquired in 2019 by Alkermes.

OverviewStructured DataIssuesContributors

Rodin Therapeutics was a biotechnology company that developed therapies for neurological disorders by applying insights gained from epigenetics. The company was founded by Ankit Mahadevia and Martin Jefson in 2013, and was headquartered in Cambridge, Massachusetts. In November 2019, Rodin Therapeutics was acquired by Alkermes.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Oryzon Genomics Develops Epigenetic Treatment for Alzheimer's

Alexander Burik

https://labiotech.eu/medical/oryzon-genomics-epigenetics-alzheimers/

News

Rodin Therapeutics Announces Initiation of Phase 1 Clinical Trial of a Selective CoREST Inhibitor to Treat Neurologic Diseases

Business Wire

https://www.businesswire.com/news/home/20181212005121/en/Rodin-Therapeutics-Announces-Initiation-Phase-1-Clinical

Web

Trial to Test New Imaging Agent for Visualizing Synapses in Living Brain

Patricia Inacio

https://parkinsonsnewstoday.com/2018/10/23/clinical-trial-tests-new-neuroimaging-agent-for-visualizing-synapses-living-brain/

Web

References

Find more companies like Rodin Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.